Varicella Vaccine Efficacy Estimates

Slides:



Advertisements
Similar presentations
Endemic or Outbreak? Differentiating recent transmission of an historic tuberculosis strain in New York City IUATLD-NAR 16 th Annual Meeting February 23-25,
Advertisements

H3N2 variant influenza A Maine, 2011 Sara Robinson, MPH Epidemiologist Maine Center for Disease Control and Prevention.
Advances in the Treatment and Prevention of Herpes Zoster and Postherpetic Neuralgia Barbara Singer, D.O.
Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
Mosquito-borne Arbovirus Surveillance in West Virginia Rachel Radcliffe, DVM, MPH CDC Career Epidemiology Field Officer Division of Infectious Disease.
Perinatal Varicella By Rafat Mosalli MD FAAP FRCPC.
Outbreak Investigation: The First 48 Rachel Radcliffe, DVM, MPH Career Epidemiology Field Officer Division of Infectious Disease Epidemiology West Virginia.
Principles of Outbreak Management
Varicella Zoster Virus Herpesvirus (DNA) Primary infection results in varicella (chickenpox) Recurrent infection results in herpes zoster (shingles) Short.
Measles and Measles Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases Centers.
Texas Influenza Surveillance Lesley Bullion Influenza Surveillance Coordinator Infectious Disease Control Unit.
2012 Fungal Meningitis Outbreak Associated With
Influenza and the Nursing Home Population Julie L. Freshwater, PhD MPH Influenza Surveillance Coordinator 1.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Texas Influenza Surveillance Lesley Bullion Influenza Surveillance Coordinator Infectious Disease Control Unit.
Rash Decisions: The Colorado Experience with “Maybe Measles” Emily Spence Davizon, Colorado Department of Public Health and Environment.
Investigation and Control of Outbreaks of Foodborne Illness Ralph Cordell, PhD.
Presentation on Field Work Careysburg District, Montserrado county By John S. Yarngrorble. DSO.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Measles Outbreak in Skopje, Republic of Macedonia, 2014 Erjona Shakjiri 1, D. Kochinski 1, Sh. Memeti 1, B. Aleksoski 1, K. Stavridis 1, V. Mikic 1, G.
DoD Global Influenza Surveillance Program Sentinel Site Surveillance at AFIOH Sequence Analysis And Vaccine Effectiveness Overview Luke T. Daum, PhD, Molecular.
Varicella and Varicella Vaccine
New York City Department of Health and Mental Hygiene
School-Based Varicella Surveillance Palm Beach County, Florida 42 nd National Immunization Conference March 17, 2008 Savita Kumar, MD, MSPH Medical Epidemiologist.
Correlation of National Influenza Surveillance Data to the Local Experience Kate Goodin, MPH Florida Department of Health Bureau of Epidemiology 6 th Annual.
Mumps and Mumps Vaccine
The Epidemiology of Varicella Disease in New York City, Janelle A. Anderson, MPH CDC/CSTE Applied Epidemiology Fellow New York City Department.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
Characterization of a Large Mumps Outbreak Among Adolescents in Jerusalem, Israel in Communities Associated with Jewish Communities in New York.
Amanda E. Faulkner, MPH Surveillance Coordinator 2011 National Immunization Conference March 30, 2011 Zooming in on Pertussis Epidemiology in the United.
Mumps Resurgence at a Large University Campus Town Awais Vaid, MBBS, MPH Epidemiologist and Director of Planning Champaign-Urbana Public Health District.
Mumps Outbreaks Associated with Correctional Facilities Texas
Using Vaccine Preventable Disease Surveillance Indicators for Evaluation (of Reporting to CDC) Denise Woods-Stout Vaccine Preventable Disease Surveillance.
Varicella & Pregnancy Dr S. Asadi Infectious diseases specialist
Director Medical Services (Health) Office of the DGMS (Army)
Outbreak Investigation
Understanding Epidemiology
Unexplained Neurologic Illness in Children – Malkangiri, Odisha, India, 2014 Authors: Priyakanta Nayak1, Mohan Papanna1, Aakash Shrivastava1, Pradeep.
Measles in the United States, : Eliminated but the Threat Is Not Gone
Jill Stauffer Field Epidemiologist – District 8 April 6, 2017
Varicella Outbreaks Among Highly Vaccinated School Children, Arkansas and Michigan 2003 Good afternoon. Recently, CDC has been hearing about outbreaks.
Quarantine and Isolation During the Sedgwick County
Evaluation of Acute Encephalitis Syndrome/ Japanese Encephalitis Surveillance System, Barpeta and Sivasagar Districts, Assam, India Dr. Takujungla.
Overview of National Surveillance for Vaccine-Preventable Diseases
CSTE Applied Epidemiology Fellow
Cynthia F. Hinton, PhD, MS, MPH
By Hatim Jaber MD MPH JBCM PhD
The presenter has no conflicts of interest to disclose.
Philip L. Gould, MD MPH Division of Viral Diseases
Copyright © 2017 American Academy of Pediatrics.
Influenza Vaccine Effectiveness Against Pediatric Deaths:
Maria del Rosario, MD, MPH Arianna DeBarr, RN, BSN
Clinical Presentation and Vaccination Status of Laboratory Confirmed PCR-Positive and PCR-Negative Varicella Cases: A Comparison Karen Kuguru, MPA Varicella.
Decline in Varicella Incidence in Texas
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
Biological Terrorism Smallpox 5/9/01.
Varicella Surveillance in Texas
Varicella Immunity among Institutionalized Adults in a Long-Term Care Facility, Georgia, September 2008 Beth Ward, R.N., M.P.H. Vaccine Preventable Disease.
Mumps Outbreak 2018.
Public Health Investigation and Response
Public Health Surveillance
Pediatric Inactivated Influenza Vaccine Safety VAERS Reports for Trivalent Inactivated Influenza Vaccine (TIV) in Infants/Toddlers Ann McMahon, MD, MS.
Employee/ Occupational Health
National Immunization Conference-April 22, 2010
National Immunization Conference
Laura Erhart, Shoana Anderson, Kelly Scranton
Serotype 10A in Invasive Pneumococcal Disease (IPD) Surveillance in New Jersey, April – September 2009 Samantha Pitts, MD, MPH CDC/CSTE Applied Epidemiology.
Mumps Vaccine Effectiveness During an Outbreak in New York City
Varicella Disease Incidence During the Introduction of a Routine Two Dose Varicella Vaccination Program, Antelope Valley, California, Amanuel.
Oregon HPV Summit - June 2019 Nasreen Abdullah, MD, MPH
Presentation transcript:

Varicella Vaccine Efficacy Estimates Dana A. Hazen, RN, MPH Indiana State Department of Health Layla Baker, MD, MPH Regenstrief Institute

Varicella Vaccination: Indiana School Requirements 2009-2010 School Year : 1 Dose K – 12th grades 2010-2011 School Year: 2 Dose K; 6-12th grade 1 Dose 1st – 5th grade Current coverage in Indiana (estimates) 1 dose (NHIS) 85.7% 2 dose (CHIRP) 70%

Varicella Surveillance: Indiana Outbreaks reportable for 10+ years Individual cases reportable as of 12/12/2008 by physicians, hospitals and laboratories through passive surveillance

Purpose Describe varicella outbreak activity in Indiana from 12/1/09 – 12/1/10 Report vaccine efficacy of 2-dose series in outbreaks

Case Definition: Chickenpox Acute onset of generalized maculopapular or vesicular rash illness in absence of other clinical diagnosis occurring <7 days or >42 days post vaccination AND Epidemiological Link to Other Case OR Positive Varicella Zoster Virus DNA detection by PCR or isolation of varicella virus from specimen through culture with clinical diagnosis of chicken pox

Outbreak Definition: Chickenpox Age 12 and Under: 5 or more cases* that are linked by person and place within 1 incubation period Age 13 and Up: 3 or more cases* that are linked by person and place within 1 incubation period. Onset dates between 12/1/09 – 12/1/10. *Cases reported by school nurses, parents or physician offices.

Data Collection: Laboratory Testing Specimens collected by nurse at school, physician’s office or local health department 2 specimens for each case Scraping of skin lesions Varicella Zoster Virus (VZV) by rapid PCR Specimen submitted to CDC VZV Lab for viral strain typing

Varicella School Outbreak Summary Form Vaccination Coverage Rates at the Onset of the First Case Number of Students: Vaccinated Once Vaccinated Twice Disease History Vaccine and Disease History No Vaccination or Disease History Unknown Vaccine History Number of Student cases Number of Staff cases

Vaccine Efficacy Calculations Vaccination Coverage Rate (%): Number of children who have received x doses varicella vaccine X 100 Number of children eligible to receive x doses varicella vaccine Vaccine Efficacy (VE) %: Attack Rate unvaccinated – Attack Rate vaccinated X 100 Attack Rate unvaccinated *Cases with known disease history or unknown vaccination status were excluded from the calculations

Results 12/1/09– 12/1/10: 388 cases reported in Indiana 11 outbreaks Involved 16 Schools Range: 5-36 cases 3 confirmed wild-type virus 147 cases linked to outbreaks No hospitalizations or deaths 4 confirmed cases 11 diagnosed by HCP

School Data N = 16 Median Age = 10 years

Disease Severity N = 142

Vaccination Status N = 146

Severity by Vaccination History N = 141

School-Based Outbreaks NUMBER OUTBREAKS CASES SCHOOLS 11 Outbreaks 147 Cases 16 Schools

School-Based Outbreaks NUMBER OUTBREAKS CASES SCHOOLS 11 Outbreaks 147 Cases 16 Schools School-side Vaccination Coverage Rates Available School-side Vaccination Coverage Rates Available 5 Outbreaks* 77 Cases 6 Schools * One outbreak missing data for 1 of the schools

School-Based Outbreaks NUMBER OUTBREAKS CASES SCHOOLS 11 Outbreaks 147 Cases 16 Schools School-side Vaccination Coverage Rates Available School-side Vaccination Coverage Rates Available 5 Outbreaks 77 cases 6 Schools Excludes staff and siblings of students 73 Cases* *There were 66 cases with known Vax Status and No History of Disease

Vaccination Coverage Rates Overall Vaccine Coverage Rate = 93.8 % Vaccine Coverage Rate for One Dose Vaccine = 65.3 % Vaccine Coverage Rate for Two Doses Vaccine = 28.4 % Vaccination Coverage Rates Outbreak Date(s) Vaccine Coverage Rate Number of cases Total 12/01/09 – 12/01/10 93.8% 73 1 01/29/10 – 03/14/10 100 % 7 2 01/18/10 – 03/31/10 99. 1% 21 3 11/11/10 – 11/27/10 64.2 % 4 08/30/10 – 09/18/10 87.3% 10 5 12/04/09 – 03/08/10 99.4 % 28

Attack Rates Vaccination Status Attack Rate Vaccinated 2.0 % 1 Dose Vaccine 2.8 % 2 Dose Vaccine 0.38% Unvaccinated 7.7%

Vaccine Efficacy Vaccination Status Estimate Overall 73.1 % 1 Dose Vaccine 63.5 % 2 Dose Vaccine 94.9 %

Limited lab Confirmations Misclassification of cases Study Limitations No Estimate exposure Low Case Counts Limited lab Confirmations Misclassification of cases No analysis of age at vaccination

Conclusion Vaccine efficacy estimates are similar to those reported by other studies Results demonstrate need for increased school requirements for the second dose of the vaccine Consider exclusion during outbreaks for unvaccinated students

Acknowledgements Centers for Disease Control and Prevention IN School Nurses IN Public Health Nurses IN State Dept of Health Field Epidemiologists

dhazen@isdh.in.gov lbaker@regenstrief.org Thank you! dhazen@isdh.in.gov lbaker@regenstrief.org